By William-Arthur Haynes
Daily Journal Staff Writer
Among the more pressing issues confronting health care practitioners today is the emergence of off-label promotion by pharmaceutical companies and its contribution to false-claims suits.
According to IMS Health, an international pharmaceutical information consultancy, the prescription drug market topped $600 billion last year. The...
Daily Journal Staff Writer
Among the more pressing issues confronting health care practitioners today is the emergence of off-label promotion by pharmaceutical companies and its contribution to false-claims suits.
According to IMS Health, an international pharmaceutical information consultancy, the prescription drug market topped $600 billion last year. The...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In